4//SEC Filing
McCarthy Daniel Joseph 4
Accession 0001628908-24-000100
CIK 0001628908other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 8:16 PM ET
Size
13.0 KB
Accession
0001628908-24-000100
Insider Transaction Report
Form 4
McCarthy Daniel Joseph
PRESIDENT
Transactions
- Exercise/Conversion
Class A Common Stock
2024-08-22$24.75/sh+4,550$112,613→ 222,502 total - Sale
Class A Common Stock
2024-08-22$30.00/sh−16,693$500,790→ 205,809 total - Sale
Class A Common Stock
2024-08-23$32.00/sh−6,469$207,008→ 192,340 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2024-08-22−4,550→ 0 totalExercise: $24.75Exp: 2027-08-01→ Class A Common Stock (4,550 underlying) - Sale
Class A Common Stock
2024-08-22$33.00/sh−7,000$231,000→ 198,809 total - Sale
Class A Common Stock
2024-08-23$33.00/sh−4,000$132,000→ 188,340 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The Class A Common Stock Options exercised vested on August 1, 2018, August 1, 2019, August 1, 2020, and August 1, 2021.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001946147
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 8:16 PM ET
- Size
- 13.0 KB